Korean Pharmaceutical Association requested Daewoong to withdraw a suit, and submit evidentiary material that UDCA is effective in fatigue recovery

Published: 2014-03-24 15:59:30

Updated: 2014-03-24 15:59:30

Korean Pharmaceutical Association directly aimed at Daewoong Pharmaceutical. On Mar 21, Korean Pharmaceutical Association announced the official position regarding to the claim for damages from Daewoong. They requested Daewoong to withdraw a suit, and submit evidentiary material that UDCA is effective in fatigue recovery.

First of all, Korean Pharmaceutical Association emphasized that as a pha...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.